• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐多药结核病:英国多中心研究(DRUMS):2008-2014 年伦敦和西米德兰兹的治疗、管理和结局。

Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.

机构信息

Institute for Infection and Immunity, St. George's University of London, London SW17 0RE, United Kingdom; Clinical Infection Unit, St George's Healthcare NHS Trust, London SW17 0QT, United Kingdom.

Division of Medicine, Imperial College London, United Kingdom.

出版信息

J Infect. 2017 Mar;74(3):260-271. doi: 10.1016/j.jinf.2016.12.005. Epub 2016 Dec 18.

DOI:10.1016/j.jinf.2016.12.005
PMID:27998752
Abstract

OBJECTIVES

Detailed information regarding treatment practices and outcomes of MDR-TB treatment in the UK is required as a baseline for care improvements.

METHODS

100 consecutive cases between 2008 and 2014 were reviewed retrospectively at 4 MDR-TB treatment centres in England to obtain information on drug treatment choices, hospital admission duration and outcomes for MDR-TB.

RESULTS

Initial hospital admission was long, median 62.5 (IQR 20-106, n = 92) days, and 13% (12/92) of patients lost their home during this period. Prolonged admission was associated with pulmonary cases, cavities on chest radiograph, a public health policy of waiting for sputum culture conversion (CC) and loss of the patient's home. Sputum CC occurred at a median of 33.5 (IQR 16-55, n = 46) days. Treatment success was high (74%, 74/100) and mortality low (1%, 1/100). A significant proportion of the cohort had "neutral" results due to deportation and transfer overseas (12%, (12/100)). 14% (14/100) had negative outcomes for which poor adherence was the main reason (62%, 9/14).

CONCLUSIONS

Successful outcome is common in recognised centres and limited by adherence rather than microbiological failure. Duration of hospital admission is influenced by lack of suitable housing and some variation in public health practice. Wider access to long-term assisted living facilities could improve completion rates.

摘要

目的

需要详细了解英国耐多药结核病(MDR-TB)治疗的治疗方法和结果,以此作为改善治疗的基准。

方法

在英格兰的 4 个 MDR-TB 治疗中心回顾性分析了 2008 年至 2014 年间的 100 例连续病例,以获取有关药物治疗选择、住院时间和 MDR-TB 结局的信息。

结果

初始住院时间长,中位数为 62.5(IQR 20-106,n=92)天,在此期间有 13%(12/92)的患者失去了家园。住院时间延长与肺部病例、胸部 X 光片有空腔、等待痰培养转化(CC)和患者失去家园的公共卫生政策有关。痰 CC 中位数为 33.5(IQR 16-55,n=46)天。治疗成功率高(74%,74/100),死亡率低(1%,1/100)。由于驱逐出境和转移到海外,该队列中有相当一部分(12%,12/100)结果呈“中性”。14%(14/100)的结果为负面,其中主要原因是药物依从性差(62%,9/14)。

结论

在公认的中心,成功的结果很常见,并且受到药物依从性而不是微生物学失败的限制。住院时间的长短受缺乏合适住房和公共卫生实践的一些差异的影响。扩大获得长期辅助生活设施的机会可以提高完成率。

相似文献

1
Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.耐多药结核病:英国多中心研究(DRUMS):2008-2014 年伦敦和西米德兰兹的治疗、管理和结局。
J Infect. 2017 Mar;74(3):260-271. doi: 10.1016/j.jinf.2016.12.005. Epub 2016 Dec 18.
2
Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.时间到痰涂片和培养转换耐多药结核在贡德尔大学医院,埃塞俄比亚西北部。
PLoS One. 2018 Jun 26;13(6):e0198080. doi: 10.1371/journal.pone.0198080. eCollection 2018.
3
Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.体重指数可预测印度尼西亚耐多药结核病患者的痰培养转阴情况。
Int J Tuberc Lung Dis. 2014 May;18(5):564-70. doi: 10.5588/ijtld.13.0602.
4
Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.埃及耐多药结核病患者的治疗预后因素
J Formos Med Assoc. 2016 Nov;115(11):997-1003. doi: 10.1016/j.jfma.2015.10.002. Epub 2015 Dec 13.
5
Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge.痰培养中检测到时间对 MDR-TB 肺病患者提前出院后的培养转归无预测价值。
J Antimicrob Chemother. 2016 Mar;71(3):803-6. doi: 10.1093/jac/dkv407. Epub 2015 Dec 11.
6
Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.比较慢性结核患者痰液和肺部病变分离的结核分枝杆菌菌株的特征。
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2063-2072. doi: 10.1007/s10096-017-3025-5. Epub 2017 Jun 15.
7
Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.通过传统培养方法从安达曼和尼科巴群岛部落及非部落肺结核患者痰液中分离结核分枝杆菌,并评估一线抗结核药物敏感性模式。
Indian J Tuberc. 2015 Jan;62(1):23-8. doi: 10.1016/j.ijtb.2015.02.004. Epub 2015 Mar 7.
8
Predictors and mortality associated with treatment default in pulmonary tuberculosis.与肺结核治疗中断相关的预测因素和死亡率。
Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.
9
Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.预测耐多药结核病患者痰培养转化的因素。
Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43. doi: 10.5588/ijtld.11.0811.
10
Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.南非开普敦凯伊利沙地区基于社区的耐多药结核病治疗
Int J Tuberc Lung Dis. 2014 Apr;18(4):441-8. doi: 10.5588/ijtld.13.0742.

引用本文的文献

1
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.利奈唑胺、德拉马尼和重新用于耐药结核病治疗的药物延长治疗后痰培养阴转。
Nat Commun. 2024 May 9;15(1):3927. doi: 10.1038/s41467-024-48077-8.
2
Inadequate housing and pulmonary tuberculosis: a systematic review.住房不足与肺结核:系统评价。
BMC Public Health. 2022 Mar 30;22(1):622. doi: 10.1186/s12889-022-12879-6.
3
Lymphocyte-Related Immunological Indicators for Stratifying Infection.淋巴细胞相关免疫指标在分层感染中的应用。
Front Immunol. 2021 Jun 30;12:658843. doi: 10.3389/fimmu.2021.658843. eCollection 2021.
4
IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial.关于采用标准化方案进行干预以提高结核病患者治疗依从性的IMPACT研究:一项混合方法研究的方案文件,包括一项试点随机对照试验。
BMJ Open. 2019 Dec 17;9(12):e032760. doi: 10.1136/bmjopen-2019-032760.
5
Whole genome sequencing for drug-resistant tuberculosis management in South Africa: What gaps would this address and what are the challenges to implementation?南非耐多药结核病管理中的全基因组测序:这将填补哪些空白,实施过程中面临哪些挑战?
J Clin Tuberc Other Mycobact Dis. 2019 Jul 9;16:100115. doi: 10.1016/j.jctube.2019.100115. eCollection 2019 Aug.
6
Linezolid for drug-resistant pulmonary tuberculosis.利奈唑胺用于耐药性肺结核
Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2.
7
An update on multidrug-resistant tuberculosis .耐多药结核病的最新进展。
Clin Med (Lond). 2019 Mar;19(2):135-139. doi: 10.7861/clinmedicine.19-2-135.
8
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.在一个耐药结核病发病率较低的国家,表型上对利福平敏感的结核分枝杆菌分离株中出现有争议的 rpoB 突变。
BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z.
9
Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.由于药物不合格导致大肠杆菌和耻垢分枝杆菌利福平耐药性的演变。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01243-18. Print 2019 Jan.
10
Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.2000-2015 年英格兰、威尔士和北爱尔兰获得性抗结核药物耐药情况。
Emerg Infect Dis. 2018 Mar;24(3):524-533. doi: 10.3201/eid2403.171362.